Updated:
Devon Park Bioventures
Devon Park Bioventures is a venture capital firm based in Wayne, Pennsylvania. It focuses on investments in therapeutics companies, medical device, diagnostic,...
Devon Park Bioventures
Devon Park Bioventures is a venture capital firm based in Wayne, Pennsylvania. It focuses on investments in therapeutics companies, medical device, diagnostic, and drug discovery technology companies. The firm has made 19 investments, including a Series B - II investment in Cardeas Pharma on April 09, 2015.
General information
Firm type
Venture Capital
Year founded
2005
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Wayne
Corporate office
Wayne, PA, United States
Principals
Brian J. O'Callaghan
Managing Director
Robert J. Wessman
Managing Director
Sector focus
Frequently asked questions
What is Devon Park Bioventures?
Devon Park Bioventures is a venture capital headquartered in Wayne, United States.
When was Devon Park Bioventures founded?
Devon Park Bioventures was founded in 2005.
Where is Devon Park Bioventures headquartered?
Devon Park Bioventures is headquartered in Wayne, United States, in the North America region.
What is Devon Park Bioventures's assets under management?
Devon Park Bioventures reports approximately Undisclosed in assets under management, as tracked by Altss.
What does Altss track for Devon Park Bioventures?
Altss maintains an OSINT-verified profile of Devon Park Bioventures covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is Devon Park Bioventures's website?
Devon Park Bioventures's public website is devonparkbioventures.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Devon Park Bioventures?
Devon Park Bioventures is classified by Altss as a Venture Capital, operating from United States within the North America region.
How does Altss source intelligence on Devon Park Bioventures?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Devon Park Bioventures's Altss profile last updated?
Devon Park Bioventures's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: